🇺🇸 LGND — Ligand Pharmaceuticals Incorporated
Salud Compra fuertePrecio actual
306,20 USD
Máx. histórico
322,75
7 días
Split 1603:1000 del 02/11/2022
Caída desde máximo
-5,13%
Rango 52 semanas
175,89 – 326,63
Variación hoy
+2,41%
Cierre anterior
299,00
Rango de hoy
297,84 – 308,26
Volumen hoy
130.173
Peor caída histórica
-93,34%
06/03/2000 → 19/11/2008
Recuperado en 2694 días
Volatilidad anualizada ⓘ
59,76%
- Nombre completo
- Ligand Pharmaceuticals Incorporated
- Divisa
- USD
- Mercado
- NasdaqGM
- Sector
- Salud
- Industria
- Biotechnology
- Empleados
- 47
- PER ⓘ
- 122,97 (puede no estar actualizado)
- Dividend yield
- 0,00% (puede no estar actualizado)
- Precio objetivo analistas
- 351,33 USD (puede no estar actualizado)
- Primera cotización
- 18/11/1992
- Precio actualizado
- hace 20 horas
Ligand Pharmaceuticals Incorporated, a biopharmaceutical company, develops and licenses biopharmaceutical assets worldwide. It offers Pradefovir, Posaconazole, Voriconazole, CAPVAXIVE, NOXAFIL, MenFive, and ZELSUVMI for infectious disease; EVOMELA and KYPROLIS for multiple myeloma; FILSPARI for the treatment of immunoglobulin a nephropathy; PNEUMOSIL, a pneumococcal conjugate vaccine to help fight against pneumococcal pneumonia in children; and QARZIBA to treat neuroblastoma. The company also provides Teriparatide injection product for osteoporosis; RYLAZE, a recombinant erwinia asparaginase for acute lymphoblastic leukemia or lymphoblastic lymphoma in adult and pediatric patients; TZIELD, a CD3-directed antibody indicated to delay the onset of Stage 3 type 1 diabetes in adults and children aged 8 years and older with Stage 2 T1D; and VAXNEUVANCE for the prevention of invasive disease caused by streptococcus pneumoniae serotypes. In addition, it offers Duavee for menopause; Frovatriptan to treat Neurology; FYCOMPA and SESQUIENT for CNS; MEKINIST for cardiology; Nexterone, a captisol-enabled formulation of amiodarone; VEKLURY, an antiviral treatment for COVID-19; and Viviant for osteoporosis. Further, the company develops ACLX-002, Ciforadenant, UGN-301, Viright, MB07133, BOT/BAL, and Lasofoxifene for oncology; Ensifentrine for respiratory disease; QTORIN for rare disease; Sparsentan for kidney disease; VK2809 for hepatology; ANEB-001 for acute cannabinoid intoxication; Reproxalap for opthamology; VK0214 for Rare Disease; and VK5211 for musculoskeletal disorder. The company was incorporated in 1987 and is based in Jupiter, Florida.
| Fecha de pago | Importe por participación |
|---|---|
| 03/04/2007 | 9,3575 USD |
| Fecha | Ratio |
|---|---|
| 02/11/2022 | 1603:1000 |
| 19/11/2010 | 1:6 |
| Fecha | Apertura | Máximo | Mínimo | Cierre | Variación | Volatilidad día | Volumen |
|---|---|---|---|---|---|---|---|
| 01/08/2011 | 8,57 | 8,61 | 8,27 | 8,44 | -0,66% | 4,00% | 193.642 |
| 29/07/2011 | 8,15 | 8,57 | 8,12 | 8,50 | +3,50% | 5,59% | 260.007 |
| 28/07/2011 | 8,23 | 8,46 | 8,13 | 8,21 | +0,08% | 3,94% | 156.453 |
| 27/07/2011 | 8,32 | 8,32 | 8,13 | 8,20 | -1,64% | 2,25% | 209.993 |
| 26/07/2011 | 7,79 | 8,41 | 7,77 | 8,34 | +7,82% | 8,25% | 318.035 |
| 25/07/2011 | 7,66 | 7,76 | 7,55 | 7,74 | +0,32% | 2,77% | 150.201 |
| 22/07/2011 | 7,61 | 7,79 | 7,43 | 7,71 | +1,23% | 4,67% | 94.898 |
| 21/07/2011 | 7,48 | 7,62 | 7,42 | 7,62 | +1,92% | 2,67% | 110.447 |
| 20/07/2011 | 7,44 | 7,48 | 7,07 | 7,47 | +0,17% | 5,53% | 80.150 |
| 19/07/2011 | 7,26 | 7,46 | 7,19 | 7,46 | +3,55% | 3,78% | 148.117 |
| 18/07/2011 | 7,19 | 7,24 | 7,04 | 7,21 | +0,00% | 2,69% | 127.919 |
| 15/07/2011 | 7,11 | 7,27 | 7,11 | 7,21 | +2,21% | 2,19% | 137.537 |
| 14/07/2011 | 6,93 | 7,11 | 6,93 | 7,05 | +1,99% | 2,61% | 85.761 |
| 13/07/2011 | 6,89 | 7,11 | 6,85 | 6,91 | +0,91% | 3,71% | 145.713 |
| 12/07/2011 | 7,09 | 7,24 | 6,81 | 6,85 | -3,51% | 6,07% | 434.092 |
| 11/07/2011 | 7,21 | 7,31 | 7,04 | 7,10 | -2,57% | 3,72% | 72.776 |
| 08/07/2011 | 7,18 | 7,29 | 7,14 | 7,29 | +0,26% | 2,08% | 62.357 |
| 07/07/2011 | 7,09 | 7,29 | 6,93 | 7,27 | +3,93% | 5,01% | 143.789 |
| 06/07/2011 | 6,97 | 7,01 | 6,89 | 6,99 | +0,00% | 1,70% | 117.981 |
| 05/07/2011 | 7,49 | 7,49 | 6,96 | 6,99 | -6,19% | 7,16% | 203.260 |
| 01/07/2011 | 7,47 | 7,60 | 7,43 | 7,45 | +0,00% | 2,34% | 199.574 |
| 30/06/2011 | 7,40 | 7,52 | 7,40 | 7,45 | +0,93% | 1,69% | 288.540 |
| 29/06/2011 | 7,50 | 7,50 | 7,32 | 7,39 | -1,50% | 2,41% | 119.904 |
| 28/06/2011 | 7,34 | 7,50 | 7,26 | 7,50 | +2,30% | 3,32% | 189.795 |
| 27/06/2011 | 6,84 | 7,39 | 6,84 | 7,33 | +6,82% | 8,02% | 334.546 |
| 24/06/2011 | 6,76 | 6,88 | 6,63 | 6,86 | +1,76% | 3,78% | 863.696 |
| 23/06/2011 | 6,61 | 6,76 | 6,59 | 6,74 | +0,65% | 2,55% | 150.041 |
| 22/06/2011 | 6,56 | 6,77 | 6,56 | 6,70 | +1,32% | 3,23% | 125.996 |
| 21/06/2011 | 6,74 | 6,79 | 6,56 | 6,61 | -0,84% | 3,43% | 184.826 |
| 20/06/2011 | 6,41 | 6,74 | 6,41 | 6,67 | +4,09% | 5,16% | 212.398 |